GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Forward PE Ratio

Bio-Rad Laboratories (Bio-Rad Laboratories) Forward PE Ratio : 24.76 (As of Apr. 26, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Forward PE Ratio?

Bio-Rad Laboratories's Forward PE Ratio for today is 24.76.

Bio-Rad Laboratories's PE Ratio without NRI for today is 24.68.

Bio-Rad Laboratories's PE Ratio for today is 0.00.


Bio-Rad Laboratories Forward PE Ratio Historical Data

The historical data trend for Bio-Rad Laboratories's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Forward PE Ratio Chart

Bio-Rad Laboratories Annual Data
Trend 2017-12 2018-11 2020-12 2021-12 2022-12 2023-12 2024-04
Forward PE Ratio
44.05 36.76 48.54 47.39 26.39 27.47 25.13

Bio-Rad Laboratories Quarterly Data
2017-03 2017-06 2017-09 2017-12 2018-03 2018-06 2018-09 2020-12 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 57.14 64.10 51.02 44.05 41.84 46.95 39.84 48.54 44.64 55.25 47.39 37.45 37.59 27.78 26.39 29.15 25.97 24.57 27.47 29.85

Competitive Comparison of Bio-Rad Laboratories's Forward PE Ratio

For the Medical Devices subindustry, Bio-Rad Laboratories's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Forward PE Ratio falls into.



Bio-Rad Laboratories Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Bio-Rad Laboratories  (NYSE:BIO.B) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Bio-Rad Laboratories Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (Bio-Rad Laboratories) Headlines